A Single-Center Randomized, Open-Label, Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 LAP in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2014
At a glance
- Drugs Cabotegravir (Primary) ; Midazolam
- Indications HIV infections
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors ViiV Healthcare
- 18 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Jan 2013 New trial record